The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,774.50
Bid: 1,774.00
Ask: 1,774.50
Change: -3.50 (-0.20%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,793.50
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 6-Coronavirus deaths rise to 6 in Seattle area as U.S. pushes for more testing

Mon, 02nd Mar 2020 15:27

(Adds details on tests for more Seattle area cases, public
health official quotes)

By David Ryder

KIRKLAND, Washington, March 2 (Reuters) - Six people in the
Seattle area have died of the illness caused by the new
coronavirus, health officials said on Monday, as authorities
across the United States scrambled to prepare for more
infections with the emphasis on increasing testing capacity.

Dr. Jeff Duchin, health officer for the Seattle and King
County Public Health agency, announced the increase in
fatalities from the previous two in Washington state.

Eight of the 14 total cases in his jurisdiction are linked
to an outbreak at a nursing facility in the Seattle suburb of
Kirkland, including four deaths, Duchin said at a news
conference.

At least four of the six people who died were either elderly
or had underlying health conditions or both, Duchin said.

The total number of cases detected by the public health
system in Washington state now stands at 18, the most of any
state. In addition to the 14 King County cases, four residents
of nearby Snohomish County have tested positive for the virus,
officials said.

"We expect the number of cases will continue to increase in
the coming days and weeks, and we are taking this situation
extremely seriously," Duchin said.

However, he also said the vast majority of diagnosed
patients have mild to moderate disease and do not need
hospitalization.

In addition to confirmed cases, King County has about 29
potential cases awaiting test results, so the number there could
soon rise, officials said. Tests were being conducted on about
200 samples per day, and health officials said they expect to
boost the number of tests to at least 1,000 a day in the near
future.

Duchin said his county was not recommending school closures
or cancellation of any events at this point.

"You can expect over the next two weeks to hear more from us
about community mitigation measures and the right time to do
it," he said. "We can't expect people to go for months and
months without going to work, without going to school," he said.

As of Sunday, the number of confirmed and presumptive cases
in the United States had risen to 91, the U.S. Centers for
Disease Control and Prevention (CDC) said. Many of those were
among people repatriated to the United States, either from the
Diamond Princess cruise ship previously quarantined in Japan or
from the Chinese city of Wuhan, where the global outbreak
originated.

The number of presumed cases reported by states but not yet
officially confirmed by the CDC stood at 27, up from seven
previously. The CDC will confirm the tests sent by states with
their own diagnostics. So far, 10 states, including California
and New York, have confirmed or presumed cases.

TEST KITS

U.S. stock markets briefly pared gains following the
announcement of an increase in fatalities but closed higher -
the S&P 500 by 4.6%, the Dow Jones by 5% and the NASDAQ by 4.5%.
World stock markets had a weeklong slide last week on
coronavirus fears.

New York Governor Andrew Cuomo welcomed a CDC decision
allowing New York to test for the virus that has killed more
than 3,000 people worldwide since it emerged in China in
December.

"I would like to have a goal of 1,000-tests-per-day capacity
within one week because, again, the more testing, the better,"
Cuomo said at a briefing on Monday.

Federal health officials have said the number of test kits
for coronavirus would be radically expanded in coming weeks. The
United States appeared poised for a spike in cases, partly
because there would be more testing to confirm infections.

Protective gear and test kits were being distributed to U.S.
military facilities with a priority on distribution to the
Korean Peninsula, the chairman of the Joint Chiefs of Staff,
Army General Mark Milley, said at a briefing.

South Korea is one of the hardest hit countries with 4,335
cases and 26 deaths.

U.S. government military laboratories were working to
develop a vaccine, Milley said.

President Donald Trump said his administration has asked
pharmaceutical companies to accelerate work on the development
of a coronavirus vaccine, but provided no details.

Top U.S. health officials have said any vaccine is up to 18
months away and there is no treatment for the respiratory
disease, although patients can receive supportive care.

Trump and his task force on the outbreak were meeting with
drug company executives on Monday afternoon. U.S. health
Secretary Alex Azar said the administration is working on supply
chain challenges for pharmaceutical companies in response to
coronavirus as many active ingredients come from China.

The White House is also expected to meet this week with top
executives from U.S. airlines and the cruise industry over the
impact of the virus to their businesses, two people briefed on
the matter said.

There have been more than 87,000 cases worldwide and nearly
3,000 deaths in 60 countries, the World Health Organization
said.

(Reporting by Steve Gorman in Los Angeles; additional reporting
by Steve Holland, David Shepardson, Susan Heavey, Lisa Lambert,
Makini Brice, David Morgan, Idrees Ali and Phil Stewart in
Washington, Michael Erman and Caroline Humer in New York and
Manas Mishra in Bengaluru, Writing by Grant McCool; Editing by
Bill Berkrot and Jonathan Oatis)

More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.